Prescribing Antipsychotics in Montenegro: a Focus Group Analysis

1. Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. Int Rev Psychiatry 2011; 23(4): 379-87.10.3109/09540261.2011.60680122026495Search in Google Scholar

2. Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P. National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy]. Nervenarzt 2013; 84(11): 1359-60,1362-4, 1366-8.10.1007/s00115-013-3913-624077969Search in Google Scholar

3. Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M, Adam G, Seemann U, Kissling W, Gaebel W. Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation-- results of a multicenter-study within the German research network on schizophrenia. Eur Arch Psychiatry Clin Neurosci 2010; 260(1): 51-7.10.1007/s00406-009-0016-219876665Search in Google Scholar

4. Busch AB, Lehman AF, Goldman H, Frank RG. Changes over time and disparities inschizophrenia treatment quality. Med Care 2009; 47(2): 199-207.10.1097/MLR.0b013e31818475b7278976619169121Search in Google Scholar

5. Barbui C, Girlanda F, Ay E, Cipriani A, Becker T, Koesters M. Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev 2014; 1: CD009780.10.1002/14651858.CD009780.pub224443146Search in Google Scholar

6. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282(15): 1458-65.10.1001/jama.282.15.145810535437Search in Google Scholar

7. Godlee F, Pakenham-Walsh N, Ncayiyana D, Cohen B, Packer A. Can we achieve health information for all by 2015? Lancet 2004; 364(9430): 295-300.Search in Google Scholar

8. Larme AC, Pugh JA. Evidence-based guidelines meet the real world: the case of diabetes care. Diabetes Care 2001; 24(10): 1728-33.10.2337/diacare.24.10.172811574433Search in Google Scholar

9. Stevović-Injac L, Đedović J, Tomčuk A. Shizofrenija - Nacionalne smjernice dobre kliničke prakse. Ministarstvo zdravlja, Radna grupa za izradu i implementaciju kliničkih protokola i smjernica i razvoj sistema osiguranja kvaliteta, Podgorica, 2012.Search in Google Scholar

10. Higashi K, Medic G, Littlewood KJ, Diez T, Granstrom O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol 2013; 3(4): 200-18.10.1177/2045125312474019380543224167693Search in Google Scholar

11. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353(12): 1209-23.10.1056/NEJMoa05168816172203Search in Google Scholar

12. De las Cuevas C, Rivero-Santana A, Perestelo-Perez L, Perez-Ramos J, Serrano-Aguilar P. Attitudes toward concordance in psychiatry: a comparative, cross-sectional study of psychiatric patients and mental health professionals. BMC Psychiatry 2012; 12: 53.10.1186/1471-244X-12-53340384822646974Search in Google Scholar

13. Addington D, McKenzie E, Smith H, Chuang H, Boucher S, Adams B, Ismail Z. Conformance to evidence- based treatment recommendations in schizophrenia treatment services. Can J Psychiatry 2012; 57(5): 317-23.10.1177/07067437120570050722546064Search in Google Scholar